-
IEM-1925 Against Soman-Induced Neurotoxicity
2026-08-17
A 2026 NeuroToxicology study tested IEM-1925 in a rat model of soman-induced status epilepticus and found combined antiseizure, neuroprotective, and cognitive benefits. Its dual AMPA/NMDA receptor strategy reduced prolonged seizure activity, hippocampal injury, and behavioral deficits more consistently than diazepam, highlighting glutamate-driven excitotoxicity as a therapeutic target.
-
CAPE NF-κB Assays in Neuroinflammation Research
2026-08-17
Caffeic Acid Phenethyl Ester (CAPE) provides a temporally controllable way to perturb NF-κB signaling in cellular and disease-model workflows. This article translates CAPE’s established inflammatory, angiogenic, and invasion-related activities into practical assay designs for testing the Stat3–NF-κB cooperation reported in a zebrafish model of Fyn-driven neurodegeneration.
-
5-Azacytidine and Bortezomib in Myeloma Cells
2026-08-16
This reference study showed that 5-azacytidine kills therapy-sensitive, therapy-resistant, and patient-derived multiple myeloma cells through DNA double-strand break responses involving ATR, followed by both caspase-dependent and caspase-independent apoptosis. Its combination data provided a preclinical rationale for pairing DNA methyltransferase inhibition with doxorubicin or Bortezomib, while also highlighting the importance of testing drug activity in microenvironmental and resistant-cell models.
-
Co-IP as a Translational Lens on Stroke Mechanisms
2026-08-15
Co-immunoprecipitation can convert a plausible signaling model into experimentally testable evidence. Using the RNF8/DAPK1 findings in ischemic stroke as a case study, this article explains how magnetic bead workflows can strengthen protein-complex isolation, improve reproducibility, and support translational decision-making.
-
V5 Epitope Tag Peptide: Mechanism and Workflow
2026-08-14
The V5 Epitope Tag Peptide is a 14-amino-acid recombinant protein expression tag with the sequence GKPIPNPLLGLDST. Its defined antigenic sequence supports antibody-based detection in Western blotting, immunoprecipitation, immunohistochemistry, localization, and interaction assays.
-
Transcription Termination Limits WEE1-Inhibitor Damage
2026-08-14
Landsverk and colleagues show that transcription termination protects replicating cells from DNA damage after WEE1 inhibition with adavosertib. Their genetic and pharmacological experiments identify transcriptional read-through as a mechanistic contributor to replication-associated damage and suggest that termination defects may influence response to WEE1-targeted treatment.
-
Sulfo-NHS-SS-Biotin for Reliable Cell Assays
2026-08-13
Learn how Sulfo-NHS-SS-Biotin (SKU A8005) can add a quantitative cell-surface protein readout to viability, proliferation, and cytotoxicity studies. This scenario-based guide covers compatibility, fresh preparation, disulfide cleavage, interpretation, and practical product-selection criteria.
-
Thapsigargin: SERCA Pump Inhibitor Workflow
2026-08-13
Use Thapsigargin as a precisely timed SERCA pump inhibitor to connect calcium flux, endoplasmic reticulum stress, apoptosis, and inflammasome biology in one experimental framework. This guide covers cell-based workflows, assay controls, concentration planning, and troubleshooting for mechanistic research.
-
USP7–PKM2 Reprogramming in Severe Pancreatitis
2026-08-12
This study identifies USP7 as an inflammatory regulator in severe acute pancreatitis by controlling PKM2 deubiquitination, phosphorylation, and nuclear trafficking in macrophages. Its combination of macrophage phenotyping, metabolic flux analysis, protein-interaction assays, and pharmacological rescue connects immune polarization with glycolytic reprogramming and supports PKM2 as a mechanistic target for further investigation.
-
Annexin V-PE Apoptosis Detection Kit Workflow
2026-08-12
Translate phosphatidylserine exposure into a rapid, fixation-free readout for drug-response studies, including GANT61-treated ALK-positive lymphoma cells. This workflow combines a 10-minute live-cell stain with flow cytometry or microscopy, plus practical controls for separating early apoptosis from later membrane failure.
-
BATF2–ATF3 Drives Mitochondrial Dysfunction in IVDD
2026-08-11
The reference study identifies a BATF2–ATF3 signaling axis that links nucleus pulposus cell stress to mitochondrial redox imbalance, apoptosis, and extracellular-matrix degradation in intervertebral disc degeneration. Its combination of human tissue analysis, genetic perturbation, mitochondrial readouts, and rescue experiments provides a mechanistic framework for evaluating BATF2–ATF3 as a potential therapeutic target.
-
Epoxomicin: A Translational Proteasome Inhibitor Strategy
2026-08-11
Epoxomicin is a selective, irreversible proteasome inhibitor that gives translational researchers a precise way to interrogate protein quality control, ER stress adaptation, inflammation, and neurodegenerative disease biology. This article connects its covalent mechanism to experimental design, validation strategy, and preclinical decision-making.
-
Bismuth Subsalicylate: GI Assay Workflows
2026-08-10
Build more reproducible gastrointestinal disorder research assays with fresh, dispersion-controlled Bismuth Subsalicylate exposure and annexin V-based membrane readouts. This workflow separates prostaglandin G/H synthase 1/2 pathway effects from phosphatidylserine exposure, particulate artifacts, and nonspecific membrane injury.
-
CX-5461: A Mechanism-First Cancer Research Guide
2026-08-09
CX-5461 is an RNA polymerase I inhibitor that connects ribosome biogenesis stress with DNA damage, mitotic catastrophe, autophagy, and senescence. This mechanism-first guide translates the latest cervical cancer findings into practical assay and interpretation strategies for cancer research.
-
Artesunate: From Ferroptosis Signal to Translation
2026-08-08
A mechanism-first guide to positioning Artesunate in oncology research, connecting ferroptosis, AKT/mTOR pathway activity, assay design, and translational decision-making beyond a single IC50 value.